Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Varian Medical Systems has received FDA 510(k) clearance for a new proton scanning dose algorithm that offers clinicians greater control over how proton beams are used to target tumors and other abnormalities.
Subscribe to our email newsletter
The new algorithm, which has been incorporated into Varian’s Eclipse treatment planning software, makes it possible to plan for intensity modulated proton therapy by optimizing dose distributions in three dimensions in order to protect surrounding healthy tissues.
Jeff Amacker, business manager for treatment planning products at Varian, said: “With proton scanning and intensity-modulation, the cumbersome process can be completely eliminated.”